Showing results (961-970 of 1,033) with videos related to

Sort By:
Pageof 104
The Lancet. Respiratory Medicine|April 12, 2021
Tremelimumab plus durvalumab retreatment and 4-year outcomes in patients with mesothelioma: a follow-up of the open label, non-randomised, phase 2 NIBIT-MESO-1 studyLuana Calabrò, Giulia Rossi, Aldo Morra, et al.
The Lancet. Respiratory Medicine|April 18, 2023
Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort studyCallum Jackson, Iain D Stewart, Tatiana Plekhanova, et al.
The Lancet. Respiratory Medicine|February 15, 2026
Budesonide-glycopyrronium-formoterol fumarate dihydrate in uncontrolled asthma (KALOS and LOGOS): twin multicentre, double-blind, double-dummy, parallel-group, randomised, phase 3 trialsAlberto Papi, Robert A Wise, David J Jackson, et al.
The Lancet. Respiratory Medicine|January 24, 2026
Burden of chronic respiratory disease in Asia, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023
The Lancet. Respiratory Medicine|January 24, 2026
Bisoprolol to prevent adverse cardiac events (PACE) in COPD: a multicentre, double-blind, randomised, controlled, phase 3 trialChristine R Jenkins, Allison Martin, Catherina L Chang, et al.
The Lancet. Respiratory Medicine|November 14, 2022
Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trialToby M Maher, Veronica A Tudor, Peter Saunders, et al.
The Lancet. Respiratory Medicine|March 26, 2023
The natural history of untreated pulmonary tuberculosis in adults: a systematic review and meta-analysisBianca Sossen, Alexandra S Richards, Torben Heinsohn, et al.
The Lancet. Respiratory Medicine|March 24, 2023
Use of digital measurement of medication adherence and lung function to guide the management of uncontrolled asthma (INCA Sun): a multicentre, single-blinded, randomised clinical trialElaine Mac Hale, Garrett Greene, Christopher Mulvey, et al.
The Lancet. Respiratory Medicine|January 30, 2023
A2BCD: a concise guide for asthma managementMarek Lommatzsch, Guy G Brusselle, Mark L Levy, et al.
The Lancet. Respiratory Medicine|December 7, 2025
First-line serplulimab plus chemotherapy with or without HLX04 versus chemotherapy in locally advanced or metastatic non-squamous non-small-cell lung cancer (ASTRUM-002): a randomised, double-blind, multicentre phase 3 trialLin Wang, Xuezhi Hao, Yanrong Hao, et al.
Pageof 104